ATE444278T1 - Neue naphtalinderivate, ihr herstellungsverfahren und die pharmazeutischen zusammensetzungen, die sie enthalten - Google Patents
Neue naphtalinderivate, ihr herstellungsverfahren und die pharmazeutischen zusammensetzungen, die sie enthaltenInfo
- Publication number
- ATE444278T1 ATE444278T1 AT07290819T AT07290819T ATE444278T1 AT E444278 T1 ATE444278 T1 AT E444278T1 AT 07290819 T AT07290819 T AT 07290819T AT 07290819 T AT07290819 T AT 07290819T AT E444278 T1 ATE444278 T1 AT E444278T1
- Authority
- AT
- Austria
- Prior art keywords
- naphtaline
- derivatives
- contain
- new
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Gynecology & Obstetrics (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Psychology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0605917A FR2903102B1 (fr) | 2006-06-30 | 2006-06-30 | Nouveaux derives naphtaleniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE444278T1 true ATE444278T1 (de) | 2009-10-15 |
Family
ID=37906940
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07290819T ATE444278T1 (de) | 2006-06-30 | 2007-06-29 | Neue naphtalinderivate, ihr herstellungsverfahren und die pharmazeutischen zusammensetzungen, die sie enthalten |
Country Status (33)
Country | Link |
---|---|
US (1) | US7462741B2 (de) |
EP (1) | EP1873140B1 (de) |
JP (1) | JP4675938B2 (de) |
KR (1) | KR100912163B1 (de) |
CN (1) | CN101096346B (de) |
AR (1) | AR061740A1 (de) |
AT (1) | ATE444278T1 (de) |
AU (1) | AU2007203044A1 (de) |
BR (1) | BRPI0702817A (de) |
CA (1) | CA2593621C (de) |
CY (1) | CY1109663T1 (de) |
DE (1) | DE602007002591D1 (de) |
DK (1) | DK1873140T3 (de) |
EA (1) | EA012283B1 (de) |
ES (1) | ES2334278T3 (de) |
FR (1) | FR2903102B1 (de) |
GE (1) | GEP20094745B (de) |
HK (1) | HK1111403A1 (de) |
HR (1) | HRP20090632T1 (de) |
MA (1) | MA29223B1 (de) |
MX (1) | MX2007007899A (de) |
MY (1) | MY142817A (de) |
NO (1) | NO20073295L (de) |
NZ (1) | NZ556188A (de) |
PL (1) | PL1873140T3 (de) |
PT (1) | PT1873140E (de) |
RS (1) | RS51079B (de) |
SG (1) | SG138589A1 (de) |
SI (1) | SI1873140T1 (de) |
TW (1) | TWI326679B (de) |
UA (1) | UA93190C2 (de) |
WO (1) | WO2008000968A1 (de) |
ZA (1) | ZA200704955B (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2903101B1 (fr) * | 2006-06-30 | 2008-09-26 | Servier Lab | Nouveaux derives naphtaleniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
CN102875408B (zh) * | 2012-10-09 | 2014-07-16 | 江西同和药业有限责任公司 | 一种阿戈美拉汀的制备方法 |
WO2014056421A1 (zh) * | 2012-10-09 | 2014-04-17 | 江西同和药业有限责任公司 | 1-氰基-1-(7-甲氧基-1-萘基)甲醇酯类化合物及其制备方法和应用 |
CN102875415B (zh) * | 2012-10-09 | 2014-08-20 | 江西同和药业有限责任公司 | 一种化合物及其制备方法和应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2689124A1 (fr) * | 1992-03-27 | 1993-10-01 | Adir | Nouvelles naphtylalkylamines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
FR2737725B1 (fr) * | 1995-08-08 | 1997-10-31 | Valentonine | Nouveaux derives acyles de la melatonine et d'analogues melatoninergiques, leur procede de preparation et leur utilisation en tant que medicament |
FR2771739B1 (fr) * | 1997-11-28 | 2001-04-20 | Adir | Nouveaux composes naphtaleniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2784375B1 (fr) * | 1998-10-12 | 2000-11-24 | Adir | Nouveaux derives cycliques a chaine cycloalkylenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2805993B1 (fr) * | 2000-03-08 | 2004-01-16 | Adir | Utilisation de ligands melatoninergiques pour l'obtention de compositions pharmaceutiques destinees a la prevention ou au traitement du developpement de la tolerance aux composes nitres |
FR2903101B1 (fr) * | 2006-06-30 | 2008-09-26 | Servier Lab | Nouveaux derives naphtaleniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2006
- 2006-06-30 FR FR0605917A patent/FR2903102B1/fr not_active Expired - Fee Related
-
2007
- 2007-06-14 MY MYPI20070960A patent/MY142817A/en unknown
- 2007-06-18 MA MA30015A patent/MA29223B1/fr unknown
- 2007-06-26 ZA ZA200704955A patent/ZA200704955B/xx unknown
- 2007-06-26 SG SG200704785-5A patent/SG138589A1/en unknown
- 2007-06-27 UA UAA200707268A patent/UA93190C2/ru unknown
- 2007-06-27 MX MX2007007899A patent/MX2007007899A/es active IP Right Grant
- 2007-06-28 US US11/823,771 patent/US7462741B2/en not_active Expired - Fee Related
- 2007-06-28 KR KR1020070064103A patent/KR100912163B1/ko not_active IP Right Cessation
- 2007-06-28 NZ NZ556188A patent/NZ556188A/en not_active IP Right Cessation
- 2007-06-28 NO NO20073295A patent/NO20073295L/no not_active Application Discontinuation
- 2007-06-29 TW TW096123645A patent/TWI326679B/zh not_active IP Right Cessation
- 2007-06-29 RS RSP-2009/0502A patent/RS51079B/sr unknown
- 2007-06-29 AT AT07290819T patent/ATE444278T1/de active
- 2007-06-29 DE DE602007002591T patent/DE602007002591D1/de active Active
- 2007-06-29 PT PT07290819T patent/PT1873140E/pt unknown
- 2007-06-29 DK DK07290819T patent/DK1873140T3/da active
- 2007-06-29 SI SI200730089T patent/SI1873140T1/sl unknown
- 2007-06-29 AU AU2007203044A patent/AU2007203044A1/en not_active Abandoned
- 2007-06-29 JP JP2007171622A patent/JP4675938B2/ja not_active Expired - Fee Related
- 2007-06-29 GE GEAP200710154A patent/GEP20094745B/en unknown
- 2007-06-29 EP EP07290819A patent/EP1873140B1/de active Active
- 2007-06-29 AR ARP070102912A patent/AR061740A1/es unknown
- 2007-06-29 CA CA2593621A patent/CA2593621C/fr not_active Expired - Fee Related
- 2007-06-29 ES ES07290819T patent/ES2334278T3/es active Active
- 2007-06-29 CN CN2007101362902A patent/CN101096346B/zh not_active Expired - Fee Related
- 2007-06-29 WO PCT/FR2007/001105 patent/WO2008000968A1/fr active Application Filing
- 2007-06-29 BR BRPI0702817-2A patent/BRPI0702817A/pt not_active IP Right Cessation
- 2007-06-29 PL PL07290819T patent/PL1873140T3/pl unknown
- 2007-06-29 EA EA200701178A patent/EA012283B1/ru not_active IP Right Cessation
-
2008
- 2008-02-21 HK HK08101883.0A patent/HK1111403A1/xx unknown
-
2009
- 2009-11-27 HR HR20090632T patent/HRP20090632T1/hr unknown
- 2009-12-16 CY CY20091101309T patent/CY1109663T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL186090A0 (en) | Cgrp antagonists, method for the production thereof, and their use as medicaments | |
IL210452A (en) | Annotations of dimethyl-oxo-dihydro- (pyridine-3-or-4-ram) -phenyl-6-methyl-6-phenyl- [1,3] -oxiazine-2-one | |
EP1888727A4 (de) | Neue dha-derivate und ihre verwendung als medikamente | |
IL193467A0 (en) | Substituted indazole derivatives, their manufacture and use as pharmaceutical agents | |
IL204052A (en) | Annotation of 1,1,1 - Tripluoro - 2 - Hydroxy - 3 - Phenylpropane | |
IL195245A0 (en) | Substituted prolinamides, production thereof and their use as drugs | |
IL212568A (en) | Annotated 4,1-Diazepan, Pharmaceutical Preparations Containing Them and Their Uses in the Preparation of Medicines for the Treatment of Diseases or Disorders of Mammals | |
IL206808A (en) | Indolyl-pyridone history, their pharmaceutical preparations and their uses | |
ATE440842T1 (de) | Neue trizyklische derivate, ihr herstellungsverfahren und pharmazeutische zusammensetzungen, die sie enthalten | |
ATE511765T1 (de) | Geschmacksfördernder fraktionierter tomatenextrakt und zusammensetzungen, die diesen enthalten | |
PL2036892T3 (pl) | Pochodne 1,2,4,5-tetrahydro-3H-benzazepin, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczne | |
IL201730A (en) | History 1h - Benzaimidazole – 2 – Il – Profile – Methyl – Amino – Ethyl – 5 – Aryl – Bicyclo [2.2.2] Oct – 5 – Ann – 2 – All, Pharmaceutical preparations containing them and their use in the preparation of drugs | |
IL218539A (en) | Annotated 4,1-Androsteadian-3-Oxo-9,6-Dihlo-16-Isoxazolidine-17-Noble N-Converted | |
WO2010121164A3 (en) | 1,4-benzodiazepinone compounds and their use in treating cancer | |
SI2030612T1 (sl) | Farmacevtski sestavek za zdravljenje opeklin in postopek za njegovo izdelavo | |
IL193155A0 (en) | Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents | |
EP1834624A4 (de) | Medizinische zusammensetzung und herstellungsverfahren dafür | |
ATE520658T1 (de) | Neue diazeniumdiolat-derivate, ihr herstellungsverfahren und sie enthaltende pharmazeutische zusammensetzungen | |
IL186862A0 (en) | Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives | |
ATE444278T1 (de) | Neue naphtalinderivate, ihr herstellungsverfahren und die pharmazeutischen zusammensetzungen, die sie enthalten | |
EP2119720A4 (de) | Neue vinblastinderivate, ihre herstellung, anwendung und pharmazeutische zusammensetzung, die diese derivate enthalten | |
ATE481393T1 (de) | Neue cycloalkyl-benzothiadiazin-derivate, ihr herstellungsverfahren und die pharmazeutischen zusammensetzungen, die sie enthalten | |
EP2402333A4 (de) | 1,4-benzothiazepin-1-oxidderivat und pharmazeutische zusammensetzung damit | |
HK1126190A1 (en) | Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them | |
DE602006008797D1 (de) | Hibitoren, und pharmazeutische zusammensetzungen, die sie enthalten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1873140 Country of ref document: EP |